Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

By: 
Michelle Zhu
08/02/18, 05:36 pm

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million investment allocation via the Startup SG Equity scheme.

Under the Startup SG Equity scheme, SSC supports early-stage startups across the technology and industry domain areas, and catalyses private-sector investments for startups via government equity co-investment.

The scheme announced its $100 million investment allocation in July 2017 to groom start-ups, and issued a call to its appointed partners to co-invest in the health & biomedical sciences and other fields.

In a Thursday announcement, Trendlines says it intends to invest in medical technology companies seeking Series A funding through its partnership with K2 Global. Both companies anticipate co-investing with SCC in more than 11 companies over the agreed partnership period of eight years.

They also consider the pipeline of deals originating from Trendlines Medical Singapore’s incubator, along with other companies that have strong development focus in Singapore, as “a rich environment for investment”.

Eric Loh, CEO of Trendlines Medical Singapore, sees the collaboration as one that leverages Trendlines’ experience and track record in identifying, incubating and grooming medical technology companies, while working closely with K2 Global to provide growth capital and support to help scale operations and facilitate global opportunities.

“This is an ideal relationship that will contribute substantial value to Singapore’s medical technology start-up ecosystem,” says Loh.

“Our participation in the Startup SG Equity program broadens our ability to develop early-stage medical technology companies in Singapore. Our collaboration with K2 Global will further strengthen our successful efforts in raising funds from strategic investors to boost the value of our portfolio companies. We expect numerous successful investment outcomes in the coming years,” adds Todd Dollinger, chairman of Trendlines Medical Singapore.

Shares in Trendlines close flat at 14 cents on Thursday. 

SGX stock falls 2% before midday break on news of potential injunction

SINGAPORE (May 22): Singapore Exchange (SGX) is facing a potential interim injunction on the India equity derivative products it intends to launch in June this year, but maintains that it nonetheless will continue to list the products as planned. To recap, SGX earlier announced its intention to launch three derivative products in June 2018 – SGX India futures, SGX India options and SGX India bank futures – to succeed the derivatives it used to offer on India’s benchmark Nifty 50. See: SGX shares opens near 7% lower on Nifty futures exit news See: Singapore turns India's Nifty in....
Read More >>

Former Malaysian PM Najib questioned by anti-graft agency

PUTRAJAYA (May 22): Former Malaysian Prime Minister Najib Razak was being questioned Tuesday by anti-corruption police about a graft scandal that could lead to criminal charges against him. He was summoned nearly two weeks after the defeat of his long-ruling coalition in national elections, a loss partly due to public anger over alleged corruption at the 1Malaysia Development Berhad (1MDB), the state investment fund that Najib set up. US investigators say Najib's associates stole and laundered US$4.5 billion ($6 billion) from the fund, some of which landed in Najib's bank account. Swa....
Read More >>

China likely to ease up slightly on financial tightening amid credit slowdown: Oxford Economics

SINGAPORE (May 22): China is likely to shift away from tighter financial policies amid a stronger-than-expected credit slowdown since December last year, even as GDP growth remains a key policy objective, according to research firm Oxford Economics. “The government has put ‘boosting domestic demand’ back on the policy agenda while de-emphasising the task of ‘deleveraging’, fuelling speculation that China is shifting away from tighter financial policies,” says lead economist Tianjie He in a report on Tuesday. However, He highlights that policymakers are not expected to make dr....
Read More >>